The epidemiology of thyroid disease

British Medical Bulletin

Volumn 99, Issue 1, 2011, Pages 39-51

  Vanderpump, Mark P J ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Epidemiology; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid disease; Thyroid nodules

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CONGENITAL HYPOTHYROIDISM; DIFFERENTIATED THYROID CANCER; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; IODINE DEFICIENCY; PRIORITY JOURNAL; SUPPLEMENTATION; THYROID CANCER; THYROID DISEASE; THYROID NODULE;

ADULT; AGE FACTORS; DIETARY SUPPLEMENTS; EFFECT MODIFIER, EPIDEMIOLOGIC; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; IODINE; MALE; MASS SCREENING; PREVALENCE; RISK FACTORS; SEX FACTORS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; TRACE ELEMENTS; UNITED STATES;

EID: 80052703117     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr030     Document Type: Article

References (34)

1. Zimmerman MB. Iodine deficiency. Endocr Rev 2009;30:376-408.
2. Vanderpump MPJ. The epidemiology of thyroid diseasesIn: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th edn. JB Lippincott-Raven: Philadelphia, 2005,398-496.
3. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34. (Pubitemid 30112276)
4. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99. (Pubitemid 34158210)
5. Laurberg P, Bulow Pedersen I, Knudsen N et al. Environmental iodine intake affects the type of non-malignant thyroid disease. Thyroid 2001;11:457-69.
6. McGrogan A, Seaman HE, Wright JW et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008;69:687-96.
7. Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in the community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93. (Pubitemid 8235965)
8. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of malignancy. Ann Intern Med 1968;69:537-40.
9. Reiners C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004;14:926-32. (Pubitemid 39612911)
10. British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer. In Perros P (ed). Report of the Thyroid Cancer Guidelines Update Group. Royal College of Physicians, London, 2007. http://www.british-thyroid-association.org/news/Docs/Thyroid-cancer-guidelines- 2007.pdf.
11. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-67.
12. Grüters A, Krude H. Update on the management of congenital hypothyroidism. Horm Res 2007;68(Suppl. 5):107-11.
13. Biondi B, Cooper DC. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131. (Pubitemid 351252748)
14. Parle JV, Franklyn JA, Cross KW et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991;34:77-83.
15. Gussekloo J, van Exel E, de Craen AJM et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-99. (Pubitemid 39577515)
16. Aghini-Lombardi F, Antonangeli L, Martino E et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano Survey. J Clin Endocrinol Metab 1999;84:561-66. (Pubitemid 29075684)
17. Knudsen N, Jørgensen T, Rasmussen S et al. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) 1999;51:361-67. (Pubitemid 29439057)
18. Wilson S, Parle JV, Roberts LM et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocrinol Metab 2006;91:4809-16. (Pubitemid 44917312)
19. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotrophin and anti-thyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92:4575-82. (Pubitemid 350223429)
20. Kanaya AM, Harris F, Volpato S et al. Association between thyroid dysfunction and total cholesterol level in an older biracial population. The Health, Aging and Body Composition Study. Arch Intern Med 2002;162:773-79. (Pubitemid 34273299)
21. Meyerovitch J, Rotman-Pikielny P, Sherf M et al. Serum thyrotrophin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med 2007;167:1533-38. (Pubitemid 47124184)
22. Vanderpump MPJ, Tunbridge WMG, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43:55-69.
23. Flynn RV, MacDonald TM, Morris AD et al. The thyroid epidemiology, audit and research study; thyroid dysfunction in the general population. J Clin Endocrinol Metab 2004;89:3879-84. (Pubitemid 39071488)
24. Leese GP, Flynn RV, Jung RT et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: The Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 2008;68:311-16.
25. Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients. A systematic review. Arch Intern Med 1999;159:658-65. (Pubitemid 29177654)
26. Drinka PJ, Amberson J, Voeks SK et al. Low TSH levels in nursing home residents not taking thyroid hormone. J Am Geriatr Soc 1996;44:573-77. (Pubitemid 26137240)
27. Schouten BJ, Brownlie BE, Frampton CM et al. Subclinical thyrotoxicosis in an outpatient population-predictors of outcome. Clin Endocrinol (Oxf) 2011;74:257-61.
28. Vadiveloo T, Donnan PT, Cochrane L et al. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011;96:59-61.
29. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007;92(8 Suppl.):S1-47. (Pubitemid 47236338)
30. Tunbridge WMG, Vanderpump MPJ. Population screening for autoimmune thyroid disease. Endocrinol Metab Clin North Am 2000;29:239-53. (Pubitemid 30396228)
31. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38. (Pubitemid 38082818)
32. Rodondi N, den Elzen WP, Bauer DC et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365-74.
33. Vanderpump MPJ. How should we manage patients with a raised serum thyrotrophin concentration?. Clin Endocrinol (Oxf) 2010;72:436-40.
34. Wartofsky L. Management of subclinical hyperthyroidism. J Clin Endocrinol Metab 2011;96:59-61.